| About WCFP
WestChina-Frontier PharmaTech (WCFP) was founded in February 2000. The facility was also known as National Chengdu New Drug Safety Evaluation Center. The company provides pre-clinical GLP drug safety and efficacy evaluation. The company is OECD, CAP, NMPA-GLP and AAALAC accredited, and has successfully passed FDA inspection.
WCFP has a staff of 580, including 7 NMPA New Drug Reviewers. WCFP also has a SQARQAP-GLP certified expert, an AAALAC expert, several national-class pathologists and more than 40 well experienced animal technicians.WCFP's GLP animal facility is 26000m2 large. It is able to conduct 130 studies (on rat, mouse, rabbit, canine, guinea pig and NHP) simultaneously.
WCFP can submit laboratory data to both NMPA and FDA, depending on clients' needs, and has so far submitted data for over 60 new drugs to FDA. WCFP employs Pristima® LIMS system developed by Xybion for electronic data collection, processing and archiving to ensure GLP data integrity. WCFP is able to provide study data in SEND format in compliance with FDA's new regulation.
2004 —— CFDA GLP Certified
2005 —— ISO 14000 Certified
2006 —— NIH OLAW Certified
2007 —— AAALAC Accredited
2009 —— China High-tech Company
2014 —— OECD GLP Certified
2014 —— CAP Certified
2016 —— OECD GLP Re-certified
2016 —— CAP Re-certified
2017 —— Successful FDA Inspection